Simplexa COVID-19 & Flu A/B Direct
K-Number: K220963 · 2023-03-17
Device Summary
Frequently Asked Questions
What is the Simplexa COVID-19 & Flu A/B Direct?
Simplexa COVID-19 & Flu A/B Direct is a medical device that received FDA 510(k) clearance on 2023-03-17. The listed applicant is Diasorin Molecular, LLC. The 510(k) number is K220963.
When did Simplexa COVID-19 & Flu A/B Direct receive FDA 510(k) clearance?
Simplexa COVID-19 & Flu A/B Direct received FDA 510(k) clearance on 2023-03-17, under 510(k) number K220963.
Who is the listed applicant for Simplexa COVID-19 & Flu A/B Direct?
The FDA 510(k) record lists Diasorin Molecular, LLC as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Simplexa COVID-19 & Flu A/B Direct?
The FDA product code for Simplexa COVID-19 & Flu A/B Direct is QOF.
Other records listing Diasorin Molecular, LLC as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: QOF)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.